Boothbay Fund Management’s BELLUS Health Inc. BLU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-119,215
Closed -$858K 2542
2023
Q1
$858K Hold
119,215
0.02% 1059
2022
Q4
$980K Buy
119,215
+4,876
+4% +$45.5K 0.02% 908
2022
Q3
$1.21M Sell
114,339
-34,082
-23% -$362K 0.03% 787
2022
Q2
$1.37M Buy
148,421
+37,325
+34% +$305K 0.04% 691
2022
Q1
$764K Buy
+111,096
New +$716K 0.02% 1073
2021
Q4
Sell
-75,225
Closed -$462K 2338
2021
Q3
$462K Sell
75,225
-53,368
-42% -$202K 0.01% 1130
2021
Q2
$400K Buy
128,593
+69,756
+119% +$266K 0.01% 1119
2021
Q1
$226K Buy
58,837
+35,160
+148% +$133K 0.01% 1314
2020
Q4
$72K Hold
23,677
﹤0.01% 1188
2020
Q3
$54K Buy
23,677
+11,494
+94% +$32.6K ﹤0.01% 999
2020
Q2
$126K Buy
+12,183
New +$123K 0.01% 856
2020
Q1
Sell
-12,183
Closed -$92K 1136
2019
Q4
$92K Sell
12,183
-287
-2% -$1.96K 0.01% 765
2019
Q3
$80K Buy
+12,470
New +$88K 0.01% 710

Other funds holding BLU

Boothbay Fund Management's BLU Position: Q2 2023 in Review

Boothbay Fund Management sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 119,215 shares — an estimated $858K sold.

Boothbay Fund Management first reported a position in BLU in Q3 2019 and held it in 13 quarters. The position peaked at $1.37M in Q2 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • Boothbay Fund Management reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • Boothbay Fund Management sold 119,215 BELLUS Health Inc. shares in Q2 2023, an estimated $858K.
  • Boothbay Fund Management first reported a position in BELLUS Health Inc. in Q3 2019 and held it in 13 quarters.
  • Boothbay Fund Management's BELLUS Health Inc. position peaked at $1.37M in Q2 2022.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Boothbay Fund Management's 13F filing for Q2 2023, filed 14 Aug 2023.